Market Need Impact Target the large obstetrics market by addressing the high rate of C sections with a minimally invasive catheter based intervention. The non prescription positioning could simplify access in hospital procurement channels, enabling faster pilot trials in obstetric units and maternal fetal medicine clinics. With a very small team, focus business development on hospital systems actively seeking to reduce C section rates and improve delivery outcomes.

Strategic Partnerships Leverage partnerships with established medtech players for manufacturing scale, regulatory support, and wide distribution. Identify strategic fit with large obstetrics portfolios among major vendors and consider licensing or co development deals to accelerate commercialization and offset capacity constraints.

Regulatory Pathway Plan regulatory path early to clear the device for market. Define the steps needed for FDA clearance and outline essential clinical endpoints to support pivotal studies and payer value demonstration.

Sales Channel Strategy Build a targeted go to market in high volume obstetric units and IDNs, with clinical champions in maternal fetal medicine leading pilots. Map procurement channels such as GPOs and distributors and develop a compelling ROI narrative around reduced C section costs and improved labor outcomes to accelerate adoption.

IP and Data Value Highlight technology and IP potential by protecting catheter design and the method through patents and pursuing outcomes data via cloud platforms. Consider a device as a service or bundled service model to align with hospital purchasing preferences and payer incentives.